AIM ImmunoTech Secures $3.3 Million Unsecured Loan from Streeterville Capital
AIM ImmunoTech Inc. has entered into a Note Purchase Agreement with Streeterville Capital, LLC, resulting in the sale of an unsecured promissory note with an original principal amount of $3,301,250. The agreement, finalized on November 18, 2025, includes an original issuance discount of $781,250 and an additional $20,000 paid by AIM ImmunoTech to cover the investor's transaction costs, bringing the net proceeds to $2,500,000. The note carries a 10% annual interest rate compounded daily and matures 24 months from issuance. AIM ImmunoTech is required to make mandatory prepayments from future fundraising, and the note includes customary default provisions, with the interest rate increasing to 22% per annum in the event of default.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AIM ImmunoTech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-024156), on November 19, 2025, and is solely responsible for the information contained therein.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。